Code Biotherapeutics, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Code Biotherapeutics, Inc.
Quantité totale PI 22
Rang # Quantité totale PI 68 579
Note d'activité PI 2,2/5.0    20
Rang # Activité PI 40 723
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

9 8
2 0
3 0
0
 
Dernier brevet 2025 - Nucleic acid carriers and therap...
Premier brevet 2009 - Long-acting dna dendrimers and m...
Dernière marque 2023 - CODE BIO
Première marque 2007 - 3DNA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Enhanced dna dendrimers and methods of use thereof. The embodiments provide compositions comprisi...
Invention Nucleic acid carriers and therapeutic methods of use. The present disclosure provides nucleic ac...
2023 P/S Pharmaceutical and therapeutic preparations in the nature of adaptable, targetable, titratable, a...
P/S Medical and scientific research and development in the field of genetic diseases, development and...
P/S Drug delivery agents in the form of multi-valent structured molecules for localized delivery of g...
Invention Enhanced dna dendrimers and methods of use thereof. The embodiments provide compositions compris...
Invention Enhanced dna dendrimers and methods of use thereof. Provided for herein are compositions comprisi...
Invention Enhanced dna dendrimers and methods of use thereof
2022 Invention Enhanced targeting using antibody-oligonucleotide conjugates. The present disclosure provides an...
Invention Enhanced targeting using antibody-oligonucleotide conjugates. The present disclosure provides ant...
2021 Invention Sirna inhibition of human antigen r expression for treatment of cancer. DNA dendrimers linked to...
2020 Invention Brain-specific angiogenesis inhibitor 1 (bai1) antibodies and uses thereof. The present disclosur...
2019 Invention Cellular delivery of dna intercalating agents. Compositions and methods for targeted delivery of ...
2017 Invention Cellular delivery of dna intercalating agents. Compositions and methods for targeted delivery of...
Invention Functionalized dna dendrimers for gene delivery to cells. Compositions are disclosed which compr...
Invention Nucleic acid carriers and therapeutic methods of use. The present disclosure provides nucleic aci...
2016 Invention Sirna inhibition of human antigen r expression for treatment of cancer. DNA dendrimer linked to ...
2013 Invention Lateral flow assays using dna dendrimers. The present invention relates to lateral flow devices ...
Invention Lateral flow assays using dna dendrimers. The present invention relates to novel lateral flow dev...
2009 Invention Long-acting dna dendrimers and methods thereof. This invention provides a unique composition whi...
Invention Long-acting dna dendrimers and methods thereof.

This invention provides a unique...
2007 P/S Chemical reagents for scientific or research use Medical diagnostic reagents